Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:39 PM
Study NCT ID:
NCT04306367
Status:
COMPLETED
Last Update Posted:
2025-02-17
First Post:
2020-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab and Olaparib in Bile Duct Cancer
Sponsor:
Georgetown University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00000908
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None